- Home
- OVLY vs KOD Comparison
OVLY vs KOD Comparison
Compare OVLY & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVLY
- KOD
- Stock Information
- Founded
- OVLY 1990
- KOD 2009
- Country
- OVLY United States
- KOD United States
- Employees
- OVLY N/A
- KOD N/A
- Industry
- OVLY Major Banks
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OVLY Finance
- KOD Health Care
- Exchange
- OVLY Nasdaq
- KOD Nasdaq
- Market Cap
- OVLY 218.4M
- KOD 198.4M
- IPO Year
- OVLY N/A
- KOD 2018
- Fundamental
- Price
- OVLY $28.59
- KOD $8.90
- Analyst Decision
- OVLY
- KOD Hold
- Analyst Count
- OVLY 0
- KOD 4
- Target Price
- OVLY N/A
- KOD $11.75
- AVG Volume (30 Days)
- OVLY 8.8K
- KOD 624.7K
- Earning Date
- OVLY 07-18-2025
- KOD 08-13-2025
- Dividend Yield
- OVLY 2.11%
- KOD N/A
- EPS Growth
- OVLY N/A
- KOD N/A
- EPS
- OVLY 2.92
- KOD N/A
- Revenue
- OVLY $79,674,000.00
- KOD N/A
- Revenue This Year
- OVLY N/A
- KOD N/A
- Revenue Next Year
- OVLY N/A
- KOD N/A
- P/E Ratio
- OVLY $9.76
- KOD N/A
- Revenue Growth
- OVLY 4.08
- KOD N/A
- 52 Week Low
- OVLY $22.70
- KOD $1.92
- 52 Week High
- OVLY $32.24
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- OVLY 62.48
- KOD 58.17
- Support Level
- OVLY $27.57
- KOD $9.10
- Resistance Level
- OVLY $28.98
- KOD $9.84
- Average True Range (ATR)
- OVLY 0.37
- KOD 0.96
- MACD
- OVLY 0.10
- KOD -0.15
- Stochastic Oscillator
- OVLY 75.93
- KOD 48.01
About OVLY Oak Valley Bancorp (CA)
Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.